Epidemiology and Clinical Features of Pulmonary Nontuberculous Mycobacteriosis in Nagasaki, Japan

Background and Objectives Recent reports indicate that the incidence of nontuberculous mycobacterial-lung disease (NTM-LD) is increasing. This study aimed to investigate the epidemiology and clinical features of NTM-LD patients in Nagasaki prefecture, Japan to identify the negative prognostic factors for NTM-LD in Japan. Methods The medical records of patients newly diagnosed with NTM-LD in eleven hospitals in Nagasaki prefecture between January 2001 and February 2010 were reviewed. Data regarding the annual population of each region and the incidence of all forms of tuberculosis were collected to assess geographic variations in NTM-LD incidence, isolates, and radiological features. Results A total 975 patients were diagnosed with NTM-LD. The incidence increased over the study period and reached 11.0 and 10.1 per 100,000 population in 2008 and 2009, respectively. M. intracellulare was the most common pathogen in the southern region, and M. avium most common in other regions. The most common radiographic pattern was the nodular-bronchiectatic pattern. Age >60 years, body mass index <18.5 kg/m2, underlying lung disease, and cavitary pattern were the negative prognostic factors at the 1-year follow-up. Conclusions The incidence of NTM-LD has been increasing in Nagasaki prefecture. The isolates and radiographic features of patients vary markedly by region.

[1]  K. Winthrop,et al.  Nontuberculous mycobacterial disease prevalence and risk factors: a changing epidemiology. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  T. Ezaki,et al.  Application of colorimetric microdilution plate hybridization for rapid genetic identification of 22 Mycobacterium species , 1991, Journal of clinical microbiology.

[3]  Robert Horsburgh,et al.  An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. , 2007, American journal of respiratory and critical care medicine.

[4]  C. F. von Reyn,et al.  Environmental risk factors for infection with Mycobacterium avium complex. , 2006, American journal of epidemiology.

[5]  R. Thomson Changing Epidemiology of Pulmonary Nontuberculous Mycobacteria Infections , 2010, Emerging infectious diseases.

[6]  D. Lie,et al.  Changing Epidemiology of Pulmonary Nontuberculous Mycobacteria Infections Rachel M. Thomson, on behalf of the NTM working group at the Queensland TB Control Centre and Queensland Mycobacterial Reference Laboratory , 2010 .

[7]  M. Raffeld,et al.  Pulmonary nontuberculous mycobacterial disease: prospective study of a distinct preexisting syndrome. , 2008, American journal of respiratory and critical care medicine.

[8]  Chun-Ta Huang,et al.  Pulmonary infection caused by nontuberculous mycobacteria in a medical center in Taiwan, 2005-2008. , 2012, Diagnostic microbiology and infectious disease.

[9]  Y. Kobashi,et al.  Comparison of clinical features in patients with pulmonary Mycobacterium-avium complex (MAC) disease treated before and after proposal for guidelines , 2004, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[10]  A. Tosteson,et al.  A cost-effectiveness analysis of universal versus selective immunization with Mycobacterium bovis bacille Calmette-Guérin in Finland. , 2003, The International Journal of Tuberculosis and Lung Disease.

[11]  E. Svandova,et al.  Six years' experience with the discontinuation of BCG vaccination , 1993 .

[12]  T. Kanauchi,et al.  Prognostic factors of 634 HIV-negative patients with Mycobacterium avium complex lung disease. , 2012, American journal of respiratory and critical care medicine.

[13]  S. Holland,et al.  Spatial clusters of nontuberculous mycobacterial lung disease in the United States. , 2012, American journal of respiratory and critical care medicine.

[14]  Y. Yamamoto,et al.  Efficacy and outcomes of clarithromycin treatment for pulmonary MAC disease. , 2005, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[15]  S. Holland,et al.  Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries. , 2012, American journal of respiratory and critical care medicine.

[16]  A. Wu,et al.  Symptomatic and health status outcomes in the Canadian randomized MAC treatment trial (CTN010) , 2000, International journal of STD & AIDS.

[17]  Y. Fujita,et al.  Analysis of Chest CT in Patients with Mycobacterium avium Complex Pulmonary Disease , 2003, Respiration.

[18]  K. Winthrop,et al.  Pulmonary nontuberculous mycobacterial disease prevalence and clinical features: an emerging public health disease. , 2010, American journal of respiratory and critical care medicine.

[19]  Mary Ann Blosky,et al.  Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. , 2010, American journal of respiratory and critical care medicine.

[20]  T. Marras,et al.  Isolation prevalence of pulmonary non-tuberculous mycobacteria in Ontario, 1997–2003 , 2007, Thorax.

[21]  D. van Soolingen,et al.  Nontuberculous Mycobacteria in Respiratory Tract Infections, Eastern Asia , 2011, Emerging infectious diseases.

[22]  H. Sørensen,et al.  Nontuberculous pulmonary mycobacteriosis in Denmark: incidence and prognostic factors. , 2010, American journal of respiratory and critical care medicine.

[23]  E. Svandova,et al.  Six years' experience with the discontinuation of BCG vaccination. 4. Protective effect of BCG vaccination against the Mycobacterium avium intracellulare complex. , 1994, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[24]  A. Clements,et al.  A spatial epidemiological analysis of nontuberculous mycobacterial infections in Queensland, Australia , 2014, BMC Infectious Diseases.

[25]  H. Hallander,et al.  Atypical mycobacteria in extrapulmonary disease among children. Incidence in Sweden from 1969 to 1990, related to changing BCG-vaccination coverage. , 1995, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[26]  T. Hirai,et al.  Genetic relatedness of Mycobacterium avium-intracellulare complex isolates from patients with pulmonary MAC disease and their residential soils. , 2013, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[27]  A. Kajiki [Non-tuberculous mycobacteriosis. What has been coming out]. , 2011, Kekkaku : [Tuberculosis].

[28]  J. Falkinham Surrounded by mycobacteria: nontuberculous mycobacteria in the human environment , 2009, Journal of applied microbiology.

[29]  L. Lebrun,et al.  Respiratory infections associated with nontuberculous mycobacteria in non-HIV patients , 2006, European Respiratory Journal.

[30]  I. Sugawara,et al.  [Identification of mycobacteria by sequencing of rpoB gene and 16S rRNA]. , 2006, Kekkaku : [Tuberculosis].

[31]  E. Wolinsky Nontuberculous mycobacteria and associated diseases. , 2015, The American review of respiratory disease.

[32]  L. Saiman,et al.  Epidemiology of Nontuberculous Mycobacteria in Patients without HIV Infection, New York City , 2008, Emerging infectious diseases.

[33]  F. Drobniewski,et al.  Increasing reports of non-tuberculous mycobacteria in England, Wales and Northern Ireland, 1995-2006 , 2010, BMC public health.

[34]  M. Iseman,et al.  The importance of nontuberculous mycobacterial lung disease. , 2008, American journal of respiratory and critical care medicine.